Related Experiment Video
Updated: Jun 6, 2026

Induction and Clinical Scoring of Chronic-Relapsing Experimental Autoimmune Encephalomyelitis
Published on: July 4, 2007
[Reversible cognitive decline in a patient with relapsing polychondritis]
S J Swen1, D J H Leonards, W A A Swen
1Klinisch geriater, Groene Hart Ziekenhuis, Gouda. sj.swen@zonnet.nl
Relapsing polychondritis, a rare autoimmune condition, can affect the brain, causing reversible dementia. Early diagnosis and treatment with prednisone resolved symptoms in a 58-year-old patient.
Area of Science:
- Rheumatology
- Neurology
- Geriatrics
Background:
- Relapsing polychondritis (RP) is a rare, progressive autoimmune disorder characterized by inflammation and destruction of cartilaginous structures.
- Neurological involvement in RP is uncommon but can manifest as cognitive impairment or dementia.
Observation:
- A 58-year-old patient presented with apathy, red eyes, bradyphrenia, and bradykinesia, alongside systemic inflammatory markers.
- The patient subsequently developed fever and bilateral inflamed ears, leading to a diagnosis of relapsing polychondritis.
Findings:
- Treatment with prednisone resulted in the complete resolution of the patient's apathy and neurological symptoms.
- The case suggests a potential link between relapsing polychondritis, cerebral vasculitis, and reversible dementia.
Implications:
- This case highlights the importance of considering autoimmune inflammatory conditions in the differential diagnosis of dementia, even in the absence of typical RP symptoms.
- Prompt recognition and management of RP-associated neurological complications may lead to favorable outcomes and cognitive recovery.
Related Concept Videos
Rheumatic Heart Disease I: Introduction
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Alzheimer Disease l: Introduction
Rheumatic Heart Disease III: Medical Management
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Rheumatic Heart Disease IV: Nursing Management